Literature DB >> 21848457

Pediatric HIV--a neglected disease?

Marc Lallemant1, Shing Chang, Rachel Cohen, Bernard Pecoul.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21848457     DOI： 10.1056/NEJMp1107275

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  25 in total

1.  Outcomes of Infants Starting Antiretroviral Therapy in Southern Africa, 2004-2012.

Authors:  Mireille Porter; Mary-Ann Davies; Muntanga K Mapani; Helena Rabie; Sam Phiri; James Nuttall; Lee Fairlie; Karl-Günter Technau; Kathryn Stinson; Robin Wood; Maureen Wellington; Andreas D Haas; Janet Giddy; Frank Tanser; Brian Eley
Journal:  J Acquir Immune Defic Syndr       Date:  2015-08-15       Impact factor: 3.731

Review 2.  Pediatric HIV/AIDS in sub-Saharan Africa: emerging issues and way forward.

Authors:  A C Ubesie
Journal:  Afr Health Sci       Date:  2012-09       Impact factor: 0.927

3.  Estimation of intracellular concentration of stavudine triphosphate in HIV-infected children given a reduced dose of 0.5 milligrams per kilogram twice daily.

Authors:  Sherwin K B Sy; Steve Innes; Hartmut Derendorf; Mark F Cotton; Bernd Rosenkranz
Journal:  Antimicrob Agents Chemother       Date:  2013-12-02       Impact factor: 5.191

4.  Authors' Reply: Early Initiation of Antiretroviral Therapy Among Young Children: A Long Way to Go.

Authors:  Manuel Koller; Kunjal Patel; Benjamin H Chi; Kara Wools-Kaloustian; Fatoumata Dicko; Kulkanya Chokephaibulkit; Cleophas Chimbetete; Rohan Hazra; Samual Ayaya; Valeriane Leroy; Huu Khanh Trong; Matthias Egger; Mary-Ann Davies
Journal:  J Acquir Immune Defic Syndr       Date:  2015-10-01       Impact factor: 3.731

5.  S-EQUOL: a neuroprotective therapeutic for chronic neurocognitive impairments in pediatric HIV.

Authors:  Kristen A McLaurin; Hailong Li; Anna K Cook; Rosemarie M Booze; Charles F Mactutus
Journal:  J Neurovirol       Date:  2020-09-01       Impact factor: 2.643

6.  White matter signal abnormalities in children with suspected HIV-related neurologic disease on early combination antiretroviral therapy.

Authors:  Christelle Ackermann; Savvas Andronikou; Barbara Laughton; Martin Kidd; Els Dobbels; Steve Innes; Ronald van Toorn; Mark Cotton
Journal:  Pediatr Infect Dis J       Date:  2014-08       Impact factor: 2.129

7.  Five-year trends in antiretroviral usage and drug costs in HIV-infected children in Thailand.

Authors:  Intira Collins; John Cairns; Sophie Le Coeur; Karin Pagdi; Chaiwat Ngampiyaskul; Prapaisri Layangool; Thitiporn Borkird; Sathaporn Na-Rajsima; Vanichaya Wanchaitanawong; Gonzague Jourdain; Marc Lallemant
Journal:  J Acquir Immune Defic Syndr       Date:  2013-09-01       Impact factor: 3.731

8.  Temporal Trends in Patient Characteristics and Outcomes Among Children Enrolled in Mozambique's National Antiretroviral Therapy Program.

Authors:  Andrew F Auld; Charity Alfredo; Eugenia Macassa; Kebba Jobarteh; Ray W Shiraishi; Emilia D Rivadeneira; James Houston; Thomas J Spira; Tedd V Ellerbrock; Paula Vaz
Journal:  Pediatr Infect Dis J       Date:  2015-08       Impact factor: 2.129

9.  Getting to 90-90-90 in paediatric HIV: What is needed?

Authors:  Mary-Ann Davies; Jorge Pinto; Marlène Bras
Journal:  J Int AIDS Soc       Date:  2015-12-02       Impact factor: 5.396

Review 10.  Treatment of young children with HIV infection: using evidence to inform policymakers.

Authors:  Andrew J Prendergast; Martina Penazzato; Mark Cotton; Philippa Musoke; Veronica Mulenga; Elaine J Abrams; Diana M Gibb
Journal:  PLoS Med       Date:  2012-07-24       Impact factor: 11.069
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.